Regenxbio
RGNX
RGNX
179 hedge funds and large institutions have $1.08B invested in Regenxbio in 2020 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 72 increasing their positions, 51 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
179
Holders Change
+9
Holders Change %
+5.29%
% of All Funds
3.68%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
26
Increased
72
Reduced
51
Closed
16
Calls
$5.76M
Puts
$5.07M
Net Calls
+$689K
Net Calls Change
+$1.71M
Top Buyers
| 1 |
BlackRock
New York
|
$204M |
| 2 |
JPMorgan Chase & Co
New York
|
$70.6M |
| 3 |
ACM
Aquilo Capital Management
San Francisco,
California
|
$20.4M |
| 4 |
State Street
Boston,
Massachusetts
|
$82.7M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
$6.77M |
Top Sellers
| 1 |
PA
Perceptive Advisors
New York
|
$0 |
| 2 |
UBS Group
Zurich,
Switzerland
|
$11.1M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
$4.41M |
| 4 |
O
OrbiMed
New York
|
$0 |
| 5 |
WM
WS Management
Jacksonville,
Florida
|
$16.1M |
